Question 1

What are the potential benefits of participating in this study?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the An Observational, Prospective Study to Assess the Efficacy and Safety of Adalloce in Patients With RA and AS clinical trial (NCT05835518). Contact the study team or your healthcare provider for specific answers.

Question 2

How will my health be monitored during the trial?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the An Observational, Prospective Study to Assess the Efficacy and Safety of Adalloce in Patients With RA and AS clinical trial (NCT05835518). Contact the study team or your healthcare provider for specific answers.

Question 3

What should I expect during the study visits?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the An Observational, Prospective Study to Assess the Efficacy and Safety of Adalloce in Patients With RA and AS clinical trial (NCT05835518). Contact the study team or your healthcare provider for specific answers.

Question 4

Are there any risks or side effects associated with Adalloce?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the An Observational, Prospective Study to Assess the Efficacy and Safety of Adalloce in Patients With RA and AS clinical trial (NCT05835518). Contact the study team or your healthcare provider for specific answers.

Question 5

How does this study compare to other treatment options I have?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the An Observational, Prospective Study to Assess the Efficacy and Safety of Adalloce in Patients With RA and AS clinical trial (NCT05835518). Contact the study team or your healthcare provider for specific answers.

Question 6

What happens if I experience side effects while participating?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the An Observational, Prospective Study to Assess the Efficacy and Safety of Adalloce in Patients With RA and AS clinical trial (NCT05835518). Contact the study team or your healthcare provider for specific answers.

What this study is about